Real Estate / REIT - Healthcare FacilitiesNYSE
$197.36
-7.97 (-3.88%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 100% · confianza 20%
FCF escenarios
weak_data · normalized FCF n/d · quality 8.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
48/100
C
Piotroski
6/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
20/100
SEC 0%
Sin guardar todavía.
Market Cap
$139.3B
P/E
95.3x
↑EV/EBITDA
65.1x
↑ROE
2.2%
↓Gross Margin
39.2%
↓Debt/Equity
0.51
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2008–2025 · 17 años de histórico normalizado
Revenue CAGR
+19.7%
FCF CAGR
—
FCF margin
26.7%
FCF / Net income
3.04x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $10.67B · net income $936.8M · FCF $2.85B
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||||||||||
| Revenue | $10.67B | $10.67B | $7.85B | $6.48B | $5.78B | $3.20B | $4.61B | $5.12B | $4.70B | $4.32B | $4.28B | $3.86B | $3.34B | $2.88B | $1.81B | $1.31B | $578.6M | $523.3M | $504.5M |
| Net Income | $936.8M | $936.8M | $951.7M | $340.1M | $141.2M | $374.5M | $1.04B | $1.33B | $829.8M | $540.6M | $1.08B | $888.5M | $512.3M | $138.3M | $294.8M | $217.6M | $128.5M | $193.3M | $283.3M |
| EBITDA | $2.31B | $2.31B | $2.78B | $2.40B | $2.04B | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| EPS | 1.39 | 1.39 | 1.57 | 0.66 | 0.30 | 0.78 | 2.33 | 3.05 | 2.02 | 1.26 | 2.81 | 2.34 | 1.45 | 0.28 | 0.98 | 0.90 | 0.83 | 1.49 | 2.76 |
| Gross Margin | 39.2% | 39.2% | 38.5% | 39.1% | 38.4% | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Operating Margin | 3.3% | 3.3% | 14.6% | 14.5% | 12.9% | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net Margin | 8.8% | 8.8% | 12.1% | 5.2% | 2.4% | 11.7% | 22.6% | 26.0% | 17.7% | 12.5% | 25.3% | 23.0% | 15.3% | 4.8% | 16.3% | 16.6% | 22.2% | 36.9% | 56.2% |
| Balance Sheet | |||||||||||||||||||
| Debt/Equity | 0.51 | 0.51 | 0.52 | 0.63 | 0.74 | 0.79 | 0.15 | 0.86 | 0.83 | 0.77 | 0.79 | 0.83 | — | 0.91 | 0.82 | 0.92 | 0.91 | — | — |
| Current Ratio | 1.65 | 1.65 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Cash Flow | |||||||||||||||||||
| Free Cash Flow | $2.85B | $2.85B | $2.20B | $1.55B | $1.30B | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Returns | |||||||||||||||||||
| ROE | 2.2% | 2.2% | 3.0% | 1.3% | 0.7% | 2.1% | 6.5% | 8.6% | 5.7% | 3.7% | 7.3% | 6.1% | 3.9% | 1.2% | 2.9% | 3.1% | 2.8% | 5.1% | — |
| Valuation | |||||||||||||||||||
| P/E | 95.34 | 95.34 | 80.14 | 134.12 | 232.60 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| EV/EBITDA | 65.12 | 65.12 | 32.34 | 25.01 | 22.94 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| P/B | 3.18 | 3.18 | 2.40 | 1.81 | 1.60 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Growth & Yield | |||||||||||||||||||
| Revenue Growth | 35.8% | 35.8% | 21.2% | 12.2% | — | -30.6% | -10.1% | 9.0% | 8.9% | 0.8% | 10.9% | 15.4% | 16.1% | 59.6% | 37.5% | 127.0% | 10.6% | 3.7% | — |
| EPS Growth | -11.5% | -11.5% | 137.9% | 120.0% | — | -66.5% | -23.6% | 51.0% | 60.3% | -55.2% | 20.1% | 61.4% | 417.9% | -71.4% | 8.9% | 8.4% | -44.3% | -46.0% | — |
| Dividend Yield | 1.5% | 1.5% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
132.7%
EPS terminal req.
$17.51
Spread vs growth
-144.2%
5Y implied EPS CAGR
72.4%
EPS terminal req.
$21.19
Spread vs growth
-83.9%
10Y implied EPS CAGR
37.7%
EPS terminal req.
$34.13
Spread vs growth
-49.2%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+29.4%
Start / end P/E
98.3x → 142.0x
EPS bridge
1.57 → 1.39
Residual
-5.1%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.